CoreAge Rx vs Revive Meds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Revive Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Revive Meds a bad call — it's best for readers interested in ordering without an advertised membership who can obtain a written prescription quote and cancellation agreement first. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Revive Meds |
|---|---|---|
| Brief Score | 94/100 (A) | 65/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current medication quote Compounded injection described; earlier $369/month listing is historical, not a current advertised total. No membership or visit fee and free shipping advertised; confirm selected order supply and financial terms. Full price detailsCompounded semaglutide injection offered; current complete medication quote unknown; earlier listing from $369/month is historical and not confirmed by the current public program |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm current medication quote Compounded injection described; earlier $459/month listing is historical, not a current advertised total. Nonapproval releases the stated card hold; thirty-day support language describes adjustment or credit, not guaranteed cash back. Full price detailsCompounded tirzepatide injection offered; current complete medication quote unknown; earlier listing from $459/month is historical and not confirmed by the current public program |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises care in all fifty states; specific services vary by provider licensing and state requirements |
| Brand-name access | Not confirmed | Reviewed named GLP-1 programs are compounded injections; current branded fulfillment was not established. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Revive Meds: Current compounded injection programs described; full selected quotes unconfirmed. Earlier $369/$459 monthly observations are historical, not current advertised totals.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.